Develops blood tests for diabetic kidney disease.
Sep 2024Revenue $2.35M/yrExpenses $27.2M/yr
No trendCash runway ≈ 1 months from Sep 2024
Figures by year
When will Renalytix be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Sep 2024, revenue was $2.35M and expenses $27.2M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jun 2024 | $2.29M | $31.9M | −$29.6M |
| Jun 2023 | $3.40M | $45.6M | −$42.2M |
| Jun 2022 | $2.97M | $56.2M | −$53.2M |
| Jun 2021 | $1.49M | $33.4M | −$31.9M |
| Jun 2020 | $0.00 | $10.3M | −$10.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.